Lipoteichoic acid induces delayed myocardial protection in isolated rat hearts: A comparison with endotoxin

Resuscitation

Volumn 79, Issue 2, 2008, Pages 311-315

  Schober, Patrick ^a,b   Oprea, Guenther ^b   Mersmann, Jan ^b   Nebert, Antje ^b   Zacharowski, Kai ^b,c   Zacharowski, Paula A ^b,c  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^c BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

LTA and LPS preconditioning; Myocardial infarct size

Indexed keywords

DEXAMETHASONE; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; EX VIVO STUDY; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEMODYNAMICS; LEUKOCYTE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; DEXAMETHASONE; DISEASE MODELS, ANIMAL; ENDOTOXINS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; LIPOPOLYSACCHARIDES; MALE; MYOCARDIAL INFARCTION; NEUTROPHILS; RATS; RATS, WISTAR; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TEICHOIC ACIDS;

EID: 54049096661     PISSN: 03009572     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resuscitation.2008.06.001     Document Type: Article

References (29)

1. Murry C.E., Jennings R.B., and Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74 (1986) 1124-1136
2. Stadnicka A., Marinovic J., Ljubkovic M., Bienengraeber M.W., and Bosnjak Z.J. Volatile anesthetic-induced cardiac preconditioning. J Anesth 21 (2007) 212-219
3. Baxter G.F., Marber M.S., Patel V.C., and Yellon D.M. Adenosine receptor involvement in a delayed phase of myocardial protection 24 h after ischemic preconditioning. Circulation 90 (1994) 2993-3000
4. Chatterjee P.K., Zacharowski K., Cuzzocrea S., et al. Lipoteichoic acid from Staphylococcus aureus reduces renal ischemia/reperfusion injury. Kidney Int 62 (2002) 1249-1263
5. Zacharowski K., Otto M., Hafner G., Chatterjee P.K., and Thiemermann C. Endotoxin induces a second window of protection in the rat heart as determined by using p-nitro-blue tetrazolium staining, cardiac troponin T release, and histology. Arterioscler Thromb Vasc Biol 19 (1999) 2276-2280
6. Zacharowski K., Frank S., Otto M., et al. Lipoteichoic acid induces delayed protection in the rat heart: a comparison with endotoxin. Arterioscler Thromb Vasc Biol 20 (2000) 1521-1528
7. Zacharowski K., Chatterjee P.K., and Thiemermann C. Delayed preconditioning induced by lipoteichoic acid from B. subtilis and S. aureus is not blocked by administration of 5-hydroxydecanoate. Shock 17 (2002) 19-22
8. Palsson-McDermott E.M., and O'Neill L.A. Signal transduction by the lipopolysaccharide receptor, toll-like receptor-4. Immunology 113 (2004) 153-162
9. Viriyakosol S., and Kirkland T.N. A region of human CD14 required for lipopolysaccharide binding. J Biol Chem 270 (1995) 361-368
10. Eising G.P., Mao L., Schmid-Schonbein G.W., Engler R.L., and Ross J. Effects of induced tolerance to bacterial lipopolysaccharide on myocardial infarct size in rats. Cardiovasc Res 31 (1996) 73-81
11. Lipton B.P., Delcarpio J.B., and McDonough K.H. Effects of endotoxin on neutrophil-mediated ischemia/reperfusion injury in the rat heart in vivo. Exp Biol Med (Maywood) 226 (2001) 320-327
12. McDonough K.H., Giaimo M.E., and Miller H.I. Effects of endotoxin on the guinea pig heart response to ischemia reperfusion injury. Shock 4 (1995) 139-142
13. Song W., Furman B.L., and Parratt J.R. Delayed protection against ischaemia-induced ventricular arrhythmias and infarct size limitation by the prior administration of Escherichia coli endotoxin. Br J Pharmacol 118 (1996) 2157-2163
14. Thiagarajan R.R., Winn R.K., and Harlan J.M. The role of leukocyte and endothelial adhesion molecules in ischemia-reperfusion injury. Thromb Haemost 78 (1997) 310-314
15. Petzelbauer P., Zacharowski P.A., Miyazaki Y., et al. The fibrin-derived peptide Bbeta15-42 protects the myocardium against ischemia-reperfusion injury. Nat Med 11 (2005) 298-304
16. Hausenloy D.J., Wynne A.M., and Yellon D.M. Ischemic preconditioning targets the reperfusion phase. Basic Res Cardiol 102 (2007) 445-452
17. Downey J.M., Davis A.M., and Cohen M.V. Signaling pathways in ischemic preconditioning. Heart Fail Rev 12 (2007) 181-188
18. Pagliaro P., Gattullo D., Rastaldo R., and Losano G. Ischemic preconditioning: from the first to the second window of protection. Life Sci 69 (2001) 1-15
19. Deuchar G.A., Opie L.H., and Lecour S. TNFalpha is required to confer protection in an in vivo model of classical ischaemic preconditioning. Life Sci 80 (2007) 1686-1691
20. Jiang X., Shi E., Nakajima Y., and Sato S. COX-2 mediates morphine-induced delayed cardioprotection via an iNOS-dependent mechanism. Life Sci 78 (2006) 2543-2549
21. Smul T.M., Lange M., Redel A., Burkhard N., Roewer N., and Kehl F. Desflurane-induced preconditioning against myocardial infarction is mediated by nitric oxide. Anesthesiology 105 (2006) 719-725
22. Rowland R.T., Cleveland J.C., Meng X., Ao L., Harken A.H., and Brown J.M. A single endotoxin challenge induces delayed myocardial protection against infarcation. J Surg Res 63 (1996) 193-198
23. Brown J.M., Grosso M.A., Terada L.S., et al. Endotoxin pretreatment increases endogenous myocardial catalase activity and decreases ischemia-reperfusion injury of isolated rat hearts. Proc Natl Acad Sci USA 86 (1989) 2516-2520
24. Nelson D.W., Brown J.M., Banerjee A., et al. Pretreatment with a nontoxic derivative of endotoxin induces functional protection against cardiac ischemia/reperfusion injury. Surgery 110 (1991) 365-369
25. Meng X., Brown J.M., Ao L., Shames B.D., Banerjee A., and Harken A.H. Reduction of infarct size in the rat heart by LPS preconditioning is associated with expression of angiogenic growth factors and increased capillary density. Shock 12 (1999) 25-31
26. Sivarajah A., McDonald M.C., and Thiemermann C. The cardioprotective effects of preconditioning with endotoxin, but not ischemia, are abolished by a peroxisome proliferator-activated receptor-gamma antagonist. J Pharmacol Exp Ther 313 (2005) 896-901
27. Shimizu M., Tamamori-Adachi M., Arai H., Tabuchi N., Tanaka H., and Sunamori M. Lipopolysaccharide pretreatment attenuates myocardial infarct size: a possible mechanism involving heat shock protein 70-inhibitory kappaBalpha complex and attenuation of nuclear factor kappaB. J Thorac Cardiovasc Surg 124 (2002) 933-941
28. Schwandner R., Dziarski R., Wesche H., Rothe M., and Kirschning C.J. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem 274 (1999) 17406-17409
29. Ma S., Xiang J., Wu J., and Hu B. Effects of lipoteichoic acid induced delayed preconditioning on ischemia-reperfusion injury in isolated rat hearts. J Huazhong Univ Sci Technolog Med Sci 23 (2003) 230-233